Aug 9 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS REPORTS SECOND QUARTER 2018 RESULTS
* QTRLY BASIC EARNINGS PER SHARE $ 0.028
* QTRLY REVENUES WERE $2,238, A DECREASE OF $242 OR 10% VERSUS PRIOR PERIOD
Aug 9 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS REPORTS SECOND QUARTER 2018 RESULTS
* QTRLY BASIC EARNINGS PER SHARE $ 0.028
* QTRLY REVENUES WERE $2,238, A DECREASE OF $242 OR 10% VERSUS PRIOR PERIOD